Fisher & Paykel Demonstrates Humidified Nasal High Flow System for Delivering Respiratory Support at MEDICA 2021
|
By HospiMedica International staff writers Posted on 18 Nov 2021 |
|
Fisher & Paykel Healthcare (F&P; Auckland, New Zealand) demonstrated its Airvo 2 nasal high flow (NHF) system that is designed to deliver proven respiratory support at MEDICA 2021.
The F&P Respiratory Care Continuum illustrates the breadth of respiratory therapies patients may require when in need of respiratory assistance. NHF is recognized by the WHO for treatment of patients with COVID-19. NHF has been used as respiratory support throughout the pandemic and its use on COVID-19 patients has been observed to keep patients off mechanical ventilation and help them stay off, lower the rate of mortality, and reduce length of stay.
The Airvo 2 is an integrated solution for delivering Optiflow high flow therapy. F&P’s leading humidification technology allows the Airvo 2 to comfortably provide high flows of humidified air (with supplemental oxygen if required) to spontaneously breathing patients, through the unique series of Optiflow interfaces. It features three temperature settings, including 37°C (body temperature pressure saturated for a normothermic patient) i.e. optimal humidity. An integrated flow generator delivers a wide flow range 10 - 60 L/min for adult patients and 2 - 25 L/min for pediatric patients, taking patients from the most acute environments (ICU and ED) to the home.
It also features F&P’s Evaqua technology which reduces the formation of mobile condensate. Oxygen can be added from a wall supply or cylinder. Its in-built ultrasonic oxygen analyzer requires no calibration, service or replacement. No separate temperature probes or heater-wire adapters are required. The Airvo 2, with its wide range of accessories, provides versatility, mobility and convenience. A compact system with a built-in flow generator means there’s no need for a noisy, heavy air compressor in order to use the Airvo 2 for transport. A suitable UPS can be added, and the Airvo 2 is ready to go.
Related Links:
Fisher & Paykel Healthcare
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Critical Care
view channel
Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis
Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more
AI Interpretability Tool for Photographed ECG Images Offers Pixel-Level Precision
The electrocardiogram (ECG) is a crucial diagnostic tool in modern medicine, used to detect heart conditions such as arrhythmias and structural abnormalities. Every year, millions of ECGs are performed... Read more
Surgical Techniques
view channel
Bioprinted Aortas Offer New Hope for Vascular Repair
Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more
Early TAVR Intervention Reduces Cardiovascular Events in Asymptomatic Aortic Stenosis Patients
Each year, approximately 300,000 Americans are diagnosed with aortic stenosis (AS), a serious condition that results from the narrowing or blockage of the aortic valve in the heart. Two common treatments... Read more
New Procedure Found Safe and Effective for Patients Undergoing Transcatheter Mitral Valve Replacement
In the United States, approximately four million people suffer from mitral valve regurgitation, the most common type of heart valve disease. As an alternative to open-heart surgery, transcatheter mitral... Read more
Patient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more
